Hollow Brook Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,384
Closed -$1.71M 89
2023
Q3
$1.71M Buy
3,384
+12
+0.4% +$6.39K 0.72% 42
2023
Q2
$1.76M Sell
3,372
-185
-5% -$99.8K 0.76% 37
2023
Q1
$2.05M Buy
3,557
+87
+3% +$49K 0.97% 32
2022
Q4
$1.91M Sell
3,470
-294
-8% -$156K 0.91% 30
2022
Q3
$1.91M Buy
3,764
+387
+11% +$217K 1.08% 26
2022
Q2
$1.83M Sell
3,377
-40
-1% -$22K 1.01% 24
2022
Q1
$2.02M Sell
3,417
-24
-0.7% -$13.8K 0.9% 25
2021
Q4
$2.3M Buy
3,441
+130
+4% +$81.2K 1.18% 23
2021
Q3
$1.89M Sell
3,311
-66
-2% -$36.2K 1.17% 24
2021
Q2
$1.7M Buy
+3,377
New +$1.59M 1.06% 25

Other funds holding TMO

Hollow Brook Wealth Management's TMO Position: Q4 2023 in Review

Hollow Brook Wealth Management sold out of Thermo Fisher Scientific (TMO) in Q4 2023, closing a stake of 3,384 shares — an estimated $1.71M sold.

Hollow Brook Wealth Management first reported a position in TMO in Q2 2021 and held it in 10 quarters. The position peaked at $2.3M in Q4 2021. 2,491 funds tracked by Wall St. Rank hold TMO as of Q4 2023.

  • Hollow Brook Wealth Management reported no remaining Thermo Fisher Scientific position as of Q4 2023 after selling out during the quarter.
  • Hollow Brook Wealth Management sold 3,384 Thermo Fisher Scientific shares in Q4 2023, an estimated $1.71M.
  • Hollow Brook Wealth Management first reported a position in Thermo Fisher Scientific in Q2 2021 and held it in 10 quarters.
  • Hollow Brook Wealth Management's Thermo Fisher Scientific position peaked at $2.3M in Q4 2021.
  • 2,491 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.

Based on Hollow Brook Wealth Management's 13F filing for Q4 2023, filed 5 Feb 2024.